Detalhe da pesquisa
1.
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.
Cell
; 182(6): 1401-1418.e18, 2020 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32810439
2.
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
N Engl J Med
; 390(14): 1265-1276, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598794
3.
Sotorasib for Lung Cancers with KRAS p.G12C Mutation.
N Engl J Med
; 384(25): 2371-2381, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34096690
4.
Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study.
Mol Cancer
; 22(1): 176, 2023 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37924050
5.
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-ß and PD-L1, in Patients With Non-Small Cell Lung Cancer Resistant or Refractory to Immune Checkpoint Inhibitors.
Oncologist
; 28(3): 258-267, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36571770
6.
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors.
N Engl J Med
; 383(13): 1207-1217, 2020 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32955176
7.
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.
N Engl J Med
; 383(9): 825-835, 2020 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32846061
8.
Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer.
N Engl J Med
; 383(9): 813-824, 2020 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32846060
9.
Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer.
J Transl Med
; 21(1): 637, 2023 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37726776
10.
Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study.
Lancet Oncol
; 23(6): 781-792, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35576957
11.
Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(1): 104-114, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34919827
12.
Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(9): 1180-1188, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35964621
13.
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.
N Engl J Med
; 381(21): 2020-2031, 2019 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31562796
14.
Functional status in older patients with lung cancer: an observational cohort study.
Support Care Cancer
; 30(5): 3817-3827, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35031829
15.
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.
N Engl J Med
; 378(24): 2288-2301, 2018 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29863955
16.
ALTA-2: Phase II study of brigatinib in patients with ALK-positive, advanced non-small-cell lung cancer who progressed on alectinib or ceritinib.
Future Oncol
; 17(14): 1709-1719, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33569983
17.
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Lancet Oncol
; 21(7): 914-922, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32539942
18.
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials.
Lancet Oncol
; 21(2): 261-270, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838015
19.
Deciphering the response and resistance to immune-checkpoint inhibitors in lung cancer with artificial intelligence-based analysis: when PIONeeR meets QUANTIC.
Br J Cancer
; 123(3): 337-338, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32541872
20.
High Serum Vitamin B12 Levels Associated with C-Reactive Protein in Older Patients with Cancer.
Oncologist
; 25(12): e1980-e1989, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32745312